Prolactinoma historical perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 3: Line 3:
{{CMG}} {{AE}} {{Anmol}}, {{Faizan}}
{{CMG}} {{AE}} {{Anmol}}, {{Faizan}}
==Overview==
==Overview==
In 1970, [[prolactin]] was discovered in humans by sensitive [[bioassay]]. In 1978, V C Medvei, President, section of history of medicine (1986-87), Royal society of medicine, London wrote in his paper that Queen Mary I of England was believed to have prolactinoma.
In 1970, [[prolactin]] was discovered in humans by sensitive [[bioassay]]. In 1978, V C Medvei, the President of the Section of History of Medicine (1986-87) of the Royal Society of Medicine in London, wrote in his paper that Queen Mary I of England was believed to have prolactinoma.


==Historical Perspective==
==Historical Perspective==
Line 11: Line 11:


== Famous Cases ==
== Famous Cases ==
* In 1978, V C Medvei, President, section of history of medicine (1986-87), Royal society of medicine, London wrote in his paper that Queen Mary I of England was believed to have prolactinoma.<ref name="pmid3323514">{{cite journal |vauthors=Medvei VC |title=The illness and death of Mary Tudor |journal=J R Soc Med |volume=80 |issue=12 |pages=766–70 |year=1987 |pmid=3323514 |pmc=1291141 |doi= |url=}}</ref>
* In 1978, V C Medvei, the President of the Section of History of Medicine (1986-87) of the Royal Society of Medicine in London, wrote in his paper that Queen Mary I of England was believed to have prolactinoma.<ref name="pmid3323514">{{cite journal |vauthors=Medvei VC |title=The illness and death of Mary Tudor |journal=J R Soc Med |volume=80 |issue=12 |pages=766–70 |year=1987 |pmid=3323514 |pmc=1291141 |doi= |url=}}</ref>


== References ==
== References ==

Revision as of 20:51, 9 August 2017

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma historical perspective

CDC on Prolactinoma historical perspective

Prolactinoma historical perspective in the news

Blogs on Prolactinoma historical perspective

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2], Faizan Sheraz, M.D. [3]

Overview

In 1970, prolactin was discovered in humans by sensitive bioassay. In 1978, V C Medvei, the President of the Section of History of Medicine (1986-87) of the Royal Society of Medicine in London, wrote in his paper that Queen Mary I of England was believed to have prolactinoma.

Historical Perspective

  • In 1928, prolactin was first extracted from cows as a lactogenic substance.[1]

Famous Cases

  • In 1978, V C Medvei, the President of the Section of History of Medicine (1986-87) of the Royal Society of Medicine in London, wrote in his paper that Queen Mary I of England was believed to have prolactinoma.[2]

References

  1. 1.0 1.1 Frantz, Andrew G. (1978). "Prolactin". New England Journal of Medicine. 298 (4): 201–207. doi:10.1056/NEJM197801262980408. ISSN 0028-4793.
  2. Medvei VC (1987). "The illness and death of Mary Tudor". J R Soc Med. 80 (12): 766–70. PMC 1291141. PMID 3323514.